Two Generations, Two Countries, One Calling
-
By
-
Hansini Laharwani
-
November 5, 2026
-
4 min
By
Hansini Laharwani
November 5, 2026
Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.
by Mouj Hijazi
October 23, 2026
How stepping away from the bench and sitting down with the patient is enhancing lives and elevating the profession
November 3, 2026
Study finds that 80 percent of patients aged 21 or younger had advanced disease at diagnosis, highlighting the importance of recognizing warning signs
November 4, 2026